Last reviewed · How we verify
NCT05525741: MFC
Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients
NA trial testing Non segmental vitiligo in Skin and Connective Tissue Diseases in 59 participants. Participants enrolled and being followed up; not accepting new ones.
1 April 2023
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nice |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 59 |
| Start date | 19 October 2022 |
| Primary completion | 1 April 2023 |
| Estimated completion | 30 June 2025 |
| Sites | 1 location across France |
Drugs / interventions tested
- Non segmental vitiligo
- Health Volunteers
Conditions studied
- Skin and Connective Tissue Diseases — all drugs for Skin and Connective Tissue Diseases →
Sponsor
Centre Hospitalier Universitaire de Nice
Who can join
Adults 18 to 80, any sex, with Skin and Connective Tissue Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the level of circulating functional mitochondria in the serum of vitiligo patients as compared to controls
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dysregulated Intracellular Signaling in the Pathogenesis of Vitiligo: An Update on Emerging Therapeutic Strategies.
Marrapodi R, Marini A, Bellei B. · · 2025 · PMID 41007740 · DOI 10.3390/biomedicines13092177
Verify or expand the search:
- PubMed search for NCT05525741
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Skin and Connective Tissue Diseases
Currently open trials in the same condition.
- NCT06427889 — Treatment Effects of Two Pharmaceutical Skin Care Creams for Xerotic Feet Among Persons with Diabetes · Phase 4 · recruiting
- NCT05185258 — Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study · Phase 4 · active not recruiting
Other Centre Hospitalier Universitaire de Nice trials
Trials by the same sponsor.
- NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
- NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
- NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
- NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
- NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05525741 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05525741.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing